Clinical Trials Directory

Trials / Sponsors / AmMax Bio, Inc.

AmMax Bio, Inc.

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis
IPF
Phase 22023-03-01
CompletedA Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT
Pigmented Villonodular Synovitis, TGCT, Tenosynovial Giant Cell Tumor
Phase 22023-01-26
TerminatedA Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, TGCT
Phase 22021-09-16
CompletedAn Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of th
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis (PVNS)
Phase 22021-05-25
CompletedSafety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer
Pancreatic Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer
Phase 1 / Phase 22016-04-14
CompletedA Study of AMG 820 in Subjects With Advanced Solid Tumors
Advanced Malignancy, Advanced Solid Tumors, Cancer
Phase 12008-03-31